EverGlade Plays Key Role on Industrial Base Expansion (IBx) Project with $39 Million in Federal Funding Secured
EverGlade (“EverGlade”), a national consulting firm, has successfully partnered with a global leader in mRNA materials used for research, diagnostics, and therapeutics, to successfully manage $39 million in federal funding. The Industrial Base Expansion (IBx) project will expand the domestic production capacity for materials that are critical to the development and manufacture of mRNA vaccines